DiaSorin SpA logo

DIA - DiaSorin SpA Share Price

‚ā¨162 -2.1  -1.3%

Last Trade - 05/03/21

Sector
Healthcare
Size
Large Cap
Market Cap £7.74bn
Enterprise Value £7.58bn
Revenue £635.9m
Position in Universe 40th / 730
Bullish
Bearish
Unlock DIA Revenue
Momentum
Relative Strength (%)
1m -9.93%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -22.5%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
443.8 499.2 569.3 637.5 669.2 706.3 873.2 1,162 +9.7%
+3.1 +17.9 +14.0 +28.3 +7.1 +12.5 +33.6 +41.9
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, DiaSorin SpArevenues increased 9% to EUR382.3M. Net income increased13% to EUR94.7M. Revenues reflect North America segmentincrease of 46% to EUR148M, Europe/Africa segment increaseof 9% to EUR179.1M. Net income benefited from OperatingProvisions decrease of 43% to EUR1.9M (expense), InterestExpense decrease of 18% to EUR998K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for DIA
Graphical History

Revenue

DIA Revenue Unlock DIA Revenue

Net Income

DIA Net Income Unlock DIA Revenue

Normalised EPS

DIA Normalised EPS Unlock DIA Revenue

PE Ratio Range

DIA PE Ratio Range Unlock DIA Revenue

Dividend Yield Range

DIA Dividend Yield Range Unlock DIA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
DIA EPS Forecasts Unlock DIA Revenue
Profile Summary

DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Public Since July 19, 2007
No. of Shareholders: n/a
No. of Employees: 1,971
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSEurofirst 300 ,
Exchange Borsa Italiana
Shares in Issue 54,775,145
Free Float (0.0%)
Eligible for
ISAs
SIPPs
DIA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for DIA
Upcoming Events for DIA
Tuesday 9th March, 2021 Estimate
Q4 2020 DiaSorin SpA Earnings Release
Tuesday 11th May, 2021 Estimate
Q1 2021 DiaSorin SpA Earnings Release
Frequently Asked Questions for DiaSorin SpA
What is the DiaSorin SpA share price?

As of 05/03/21, shares in DiaSorin SpA are trading at ‚ā¨162, giving the company a market capitalisation of ¬£7.74bn. This share price information is delayed by 15 minutes.

How has the DiaSorin SpA share price performed this year?

Shares in DiaSorin SpA are currently trading at ‚ā¨162 and the price has moved by 56.43% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the DiaSorin SpA price has moved by 46.29% over the past year.

What are the analyst and broker recommendations for DiaSorin SpA?

Of the analysts with advisory recommendations for DiaSorin SpA, there are there are currently 1 "buy" , 6 "hold" and 1 "sell" recommendations. The overall consensus recommendation for DiaSorin SpA is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will DiaSorin SpA next release its financial results?

DiaSorin SpA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the DiaSorin SpA dividend yield?

The DiaSorin SpA dividend yield is 0.58% based on the trailing twelve month period.

Does DiaSorin SpA pay a dividend?

Last year, DiaSorin SpA paid a total dividend of 0.95, and it currently has a trailing dividend yield of 0.58%. Looking ahead, DiaSorin SpA has not announced an ex-dividend date yet.

When does DiaSorin SpA next pay dividends?

DiaSorin SpA has yet to annouce their ex-dividend date. The historic dividend yield on DiaSorin SpA shares is currently 0.58%.

How do I buy DiaSorin SpA shares?

To buy shares in DiaSorin SpA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of DiaSorin SpA?

Shares in DiaSorin SpA are currently trading at ‚ā¨162, giving the company a market capitalisation of ¬£7.74bn.

Where are DiaSorin SpA shares listed? Where are DiaSorin SpA shares listed?

Here are the trading details for DiaSorin SpA:

Country of listing: Italy
Exchange: MIL
Ticker Symbol: DIA
What kind of share is DiaSorin SpA?

Based on an overall assessment of its quality, value and momentum, DiaSorin SpA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a DiaSorin SpA share price forecast 2021?

Shares in DiaSorin SpA are currently priced at ‚ā¨162. At that level they are trading at 5.2% discount to the analyst consensus target price of 0.00.

Analysts covering DiaSorin SpA currently have a consensus Earnings Per Share (EPS) forecast of 4.365 for the next financial year.

How can I tell whether the DiaSorin SpA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DiaSorin SpA. Over the past six months, the relative strength of its shares against the market has been 3.69%. At the current price of ‚ā¨162, shares in DiaSorin SpA are trading at -4.34% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the DiaSorin SpA PE Ratio?

The DiaSorin SpA PE ratio based on its reported earnings over the past 12 months is 47.05. The shares are currently trading at ‚ā¨162.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of DiaSorin SpA?

DiaSorin SpA's management team is headed by:

Gustavo Denegri - NEC
Chen Even - EDR
Michele Denegri - NVC
Giuseppe Alessandria - LED
Stefano Ronchi - SVP
Carlo Rosa - CEO
Riccardo Fava - VPR
Stefano Altara - NED
Piergiorgio Pedron - CFO
Giancarlo Boschetti - NED
Ugo Gay - SVP
John Gerace - CEX
Who are the major shareholders of DiaSorin SpA?

Here are the top five shareholders of DiaSorin SpA based on the size of their shareholding:

Finde SS Corporation
Percentage owned: 44.98% (25.2m shares)
Rosa (Carlo) Individual Investor
Percentage owned: 8.36% (4.68m shares)
Even Chen (Menachem) Individual Investor
Percentage owned: 4.2% (2.35m shares)
T. Rowe Price Associates, Inc. Investment Advisor
Percentage owned: 3.03% (1.70m shares)
Columbia Threadneedle Investments (UK) Investment Advisor/Hedge Fund
Percentage owned: 1.17% (653k shares)
Similar to DIA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.